Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer

Toll-like receptor-9 (TLR9) is a member of the innate immune system and recognizes bacterial and vertebrate DNA in cells. In addition to being expressed in cells of the immune system, it is widely expressed in various types of human cancer, including prostate cancer. We have previously demonstrated...

Descripción completa

Detalles Bibliográficos
Autores principales: VÄISÄNEN, MARJA-RIITTA, JUKKOLA-VUORINEN, ARJA, VUOPALA, KATRI S., SELANDER, KATRI S., VAARALA, MARKKU H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678868/
https://www.ncbi.nlm.nih.gov/pubmed/23761830
http://dx.doi.org/10.3892/ol.2013.1204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678868/
https://www.ncbi.nlm.nih.gov/pubmed/23761830
http://dx.doi.org/10.3892/ol.2013.1204

Ejemplares similares